Skip to content

Author

I. V. Feldblyum

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Safety and Immunogenicity of First Russian Quadrivalent (Recombinant, Adsorbed) Human Papillomavirus (Types 6, 11, 16, 18) Vaccine in Children Aged 9–17 Years: Multicenter, Randomized, Double-Blind, Phase III Clinical Trial

Background . Human papillomavirus (HPV) infection is a significant risk factor for the development of HPV-associated precancerous and malignant diseases. Recombinant adsorbed vaccine against HPV (types 6, 11, 16, and 18) has been developed in Russian Federation to prevent these conditions. Vaccine immunogenicity and...

I. V. Feldblyum, K. A. Subbotina, E. Uvarova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.